Physician profile
Margaret E Smith
NPI 1982357323
$2,084.76
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $628 · 2023: $1,457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,456.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,433.54 | 2022-2023 | |
| Janssen Biotech, INC. | $154.54 | 2023 | Tremfya, Simponi Aria |
| Janssen Scientific Affairs, LLC | $135.00 | 2023 | Tremfya |
| Amgen INC. | $105.24 | 2022-2023 | Enbrel, Otezla |
| Astrazeneca Pharmaceuticals LP | $90.30 | 2023 | Saphnelo |
| Horizon Therapeutics Plc | $90.30 | 2022 | |
| Ucb, INC. | $32.00 | 2022 | |
| Sandoz INC. | $15.69 | 2023 | Hyrimoz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.54 | 2023 | |
| Radius Health, INC. | $12.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.